氨酸信号传递促进了Takotsubo综合征的发生
Bastian Bruns1,2,3,4, Marilena Antoniou1,3,4, Irena Baier1,3,4
1Institute of Experimental Cardiology, Heidelberg University Hospital, Heidelberg, Germany.
Nature cardiovascular research
|August 28, 2024
概括
塔科苏博综合征 (TTS) 是一种由压力引起的心脏病. 在临床前模型中,氨酸抑制剂通过改善心脏功能和减少损伤来治疗TTS具有前景.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 塔科苏博综合征 (TTS) 是一种类似于心肌梗塞的急性心力衰竭综合征,通常是由压力引发的.
- 目前,对于TTS.没有特定的治疗方法.
- 雄性小鼠在应对压力时表现出增加的死亡率和心肌损伤,反映了人类的性别差异.
研究的目的:
- 调查TTS的潜在机制,并确定潜在的治疗点.
- 在TTS的临床前模型中评估氨酸抑制剂的疗效.
主要方法:
- 在小鼠中注射上腺素 (EPI),以模拟TTS.
- 心肌RNA测序和基因组丰富分析.
- 在循环细胞中测定氨酸活性.
- 在注射EPI的小鼠中使用氨酸抑制剂 (环素,塔克罗利斯) 治疗.
主要成果:
- 在小鼠中注射EPI重述了人类TTS的关键特征,男性的死亡率和心肌损伤更高.
- 在EPI后,氨酸依赖的炎症基因网络显著增强,特别是在男性中.
- 在TTS患者的循环细胞中观察到氨酸活性增加.
- 在接受治疗的小鼠中,氨酸抑制剂改善了心脏功能,减少了心肌损伤.
结论:
- 氨酸信号传递在TTS的发病过程中起着至关重要的作用,有性别特异的差异.
- 卡尔西纽林抑制代表了Takotsubo综合征的潜在治疗策略.
相关概念视频
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
404
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
Endocrine Signaling
64.1K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
64.1K
GPCR Desensitization
5.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.9K
Amplifying Signals via Enzymatic Cascade
8.4K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.4K


